The expanding role of pyridine and dihydropyridine scaffolds in drug design

Y Ling, ZY Hao, D Liang, CL Zhang… - Drug design …, 2021 - Taylor & Francis
Pyridine-based ring systems are one of the most extensively used heterocycles in the field of
drug design, primarily due to their profound effect on pharmacological activity, which has led …

Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials

CO Stiller, P Hjemdahl - Journal of Internal Medicine, 2022 - Wiley Online Library
Nonsteroidal anti‐inflammatory drugs (NSAIDs) inhibit the enzyme cyclooxygenase (COX),
which forms prostaglandins involved in pain and inflammation. COX inhibitors have …

New insights into the use of currently available non-steroidal anti-inflammatory drugs

K Brune, P Patrignani - Journal of pain research, 2015 - Taylor & Francis
Non-steroidal anti-inflammatory drugs (NSAIDs), which act via inhibition of the
cyclooxygenase (COX) isozymes, were discovered more than 100 years ago. They remain a …

Use of NSAIDs in treating patients with arthritis

LJ Crofford - Arthritis research & therapy, 2013 - Springer
Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost
universally describe pain and stiffness as important contributors to reduced health-related …

Role of nonsteroidal anti‐inflammatory drugs (NSAIDs) in cancer prevention and cancer promotion

RSY Wong - Advances in Pharmacological and Pharmaceutical …, 2019 - Wiley Online Library
The nonsteroidal anti‐inflammatory drugs (NSAIDs) are commonly prescribed by medical
practitioners in many clinical conditions for the symptomatic treatment of pain and fever. Due …

Diclofenac use and cardiovascular risks: series of nationwide cohort studies

M Schmidt, HT Sørensen, L Pedersen - bmj, 2018 - bmj.com
Objective To examine the cardiovascular risks of diclofenac initiation compared with
initiation of other traditional non-steroidal anti-inflammatory drugs, initiation of paracetamol …

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of …

M Schmidt, M Lamberts, AMS Olsen… - European heart …, 2016 - academic.oup.com
Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) have been used in clinical
practice for more than a century and are among the most widely used drugs worldwide for …

Cyclooxygenase inhibitors: from pharmacology to clinical read-outs

P Patrignani, C Patrono - Biochimica et Biophysica Acta (BBA)-Molecular …, 2015 - Elsevier
Acetylsalicylic acid (aspirin) is a prototypic cyclooxygenase (COX) inhibitor. It was
synthesized serendipitously from a natural compound, ie, salicylic acid, with known …

The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs

T Grosser, E Ricciotti, GA FitzGerald - Trends in pharmacological sciences, 2017 - cell.com
The principal molecular mechanisms underlying the cardiovascular (CV) and renal adverse
effects of nonsteroidal anti-inflammatory drugs (NSAIDs), such as myocardial infarction and …

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population

LA García Rodríguez, S Tacconelli… - Journal of the American …, 2008 - jacc.org
Objectives: We studied the association between the frequency, dose, and duration of
different nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of myocardial infarction …